Abstract
Aim
To compare the outcomes of Ahmed glaucoma valve (AGV) pediatric FP8 versus the large-sized adult FP7 implants in an adult secondary glaucoma.
Methods
Patients who underwent AGV implantation from January 2011 to December 2016 for adult secondary glaucoma (due to causes other than post-vitreoretinal/buckle surgery glaucoma) with a follow-up of 6 months were included for this retrospective study. Success was defined as IOP > 6 mm Hg and < 21 mm Hg without any loss of vision, with or without the need of anti-glaucoma medications or additional procedures for control of IOP. Hypertensive phase was defined as IOP > 21 mmHg at any visit in the first 6 months of postoperative follow-up period, while failure was defined as IOP > 21 mm Hg even after medications or additional procedures, need of removal of implant or loss of light perception. Cumulative survival rates and intraoperative or postoperative complications along with IOP profiles were compared between the implants.
Results
Of 43 patients, 19 patients underwent FP7 and 24 patients underwent FP8 Ahmed Glaucoma valve implantation. The IOP significantly reduced in both groups from baseline (31 ± 8.2 mm Hg in FP7 eyes and 37 ± 13.1 mm Hg in FP8 eyes) by a mean of 64 ± 23.5% in FP8 and 64 ± 21.5% in FP7 group, respectively, p = 0.8 with comparable final IOP of 16.5 mm Hg and 16.9 mm Hg, respectively, p = 0.9. Both groups had 75% qualified success rates at 20 months after surgery with similar rates of need for postoperative medications or incidence of hypertensive phase. The FP8 eyes had more frequent conjunctiva-related complications in eyes with prior surgeries and preoperative conjunctival scarring while the other complications were similar in the two groups.
Conclusion
Surgical outcomes of adult FP7 and pediatric FP8 AGV in adult secondary glaucoma seem to achieve similar IOP control and success rates. This suggests that smaller-sized FP8 can be used in adult glaucoma with good surgical outcomes albeit with careful case selection in eyes with extensive preoperative scarring to avoid conjunctival thinning-related complications postoperatively.
Similar content being viewed by others
References
Gedde SJ, Sffman JC, Feuer WJ et al (2007) Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol 143:9–22
Patel S, Pasquale LR (2010) Glaucoma drainage devices: a review of the past, present, and future. Semin Ophthalmol 25:265–270
Giovingo M (2014) Complications of glaucoma drainage device surgery: a review. Semin Ophthalmol 29:397–402
Nouri-Mahdavi K, Caprioli J (2003) Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol 136:1001–1008
Richter CU, Shingleton BJ, Bellows AR et al (1988) The development of encapsulated filtering blebs. Ophthalmology 95:1163–1168
Herschler J, Claflin AJ, Fiorentino G (1980) The effect of aqueous humor on the growth of subconjunctival fibroblasts in tissue culture and its implications for glaucoma surgery. Am J Ophthalmol 89:245–249
Seah SK, Gazzard G, Aung T (2003) Intermediate-term outcome of Baerveldt glaucoma implants in Asian eyes. Ophthalmology 110:888–894
Zhu Y, Wei Y, Yang X et al (2015) Clinical outcomes of FP-7/8 Ahmed glaucoma valves in the management of refractory glaucoma in the mainland Chinese population. PLoS ONE 10(5):21
Bikbov MM, Khusnitdinov II (2015) The results of the use of Ahmed valve in refractory glaucoma surgery. J Curr Glaucoma Pract 9:86–91
Budenz DL, Barton K, Gedde SJ, Ahmed Baerveldt Comparison Study Group et al (2015) The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology 122:308–316
Heuer DK, Lloyd MA, Abrams DA et al (1992) Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology 99:1512–1519
Lloyd MA, Baerveldt G, Fellenbaum PS et al (1994) Intermediate-term results of a randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant. Ophthalmology 101:1456–1463
Britt MT, LaBree LD, Lloyd MA et al (1999) Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better? Ophthalmology 106:2312–2318
Koh KM, Hwang YH, Jung JJ et al (2013) Comparison of the outcome of silicone Ahmed glaucoma valve implantation with a surface area between 96 and 184 mm2 in adult eyes. Korean J Ophthalmol 27:361–367
Won HJ, Sung KR (2016) Hypertensive phase following silicone plate Ahmed glaucoma valve implantation. J Glaucoma 25:e313–e317
Thieme H, Choritz L, Hofmann-Rummelt C et al (2011) Histopathologic findings in early encapsulated blebs of young patients treated with the Ahmed glaucoma valve. J Glaucoma 20:246–251
Cui QN, Hsia YC, Lin SC et al (2017) Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. Clin Exp Ophthalmol 45:128–134
Ayyala RS, Zurakowski D, Smith JA et al (1998) A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105(1968–1976):3
Jiménez-Román J, Gil-Carrasco F, Costa VP et al (2016) Intraocular pressure control after the implantation of a second Ahmed glaucoma valve. Int Ophthalmol 36:347–353
Jung KI, Park CK (2016) Risk factors for the hypertensive phase after implantation of a glaucoma drainage device. Acta Ophthalmol 94:e260–e267
Jung KI, Park H, Jung Y et al (2015) Serial changes in the bleb wall after glaucoma drainage implant surgery: characteristics during the hypertensive phase. Acta Ophthalmol 93:e248–e253
Sahyoun MA, Farhat RG, Nehme JCB et al (2017) Ahmed glaucoma valve in various etiologies of refractory glaucoma: surgical outcomes and success factors. J Fr Ophtalmol 40:770–776
Riva I, Roberti G, Oddone F et al (2017) Ahmed glaucoma valve implant: surgical technique and complications. Clin Ophthalmol 11:357–367
Funding
No funding has been declared.
Author information
Authors and Affiliations
Contributions
APR contributed to conception and design. RS/APR/MHA contributed to data acquisition. APR/RS/MHA contributed to data analysis/interpretation. APR/RS contributed to manuscript preparation. APR contributed to manuscript critical revision/proofreading.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Human and animal rights
This research involves human participants and/or animals, with institutional review board approval from MTC campus, Bhubaneswar.
Informed consent
Informed consent has been obtained from all patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ramyashri, S., Raj, N., Pradhan, A. et al. Outcomes of Ahmed glaucoma valve FP8 versus FP7 in adult secondary glaucoma. Int Ophthalmol 40, 1359–1366 (2020). https://doi.org/10.1007/s10792-020-01301-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01301-y